Suppr超能文献

尺寸很重要:通过调节颗粒大小改变抗原特异性免疫耐受。

Size matters: Altering antigen specific immune tolerance by tuning size of particles.

作者信息

Li Baisong, Ma Lin, Li Xiwen, Suleman Zainab, Liu Changming, Piskareva Olga, Liu Mi

机构信息

Kunshan Hospital of Traditional Chinese Medicine, Kunshan, Jiangsu 215300, People's Republic of China; College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215123, People's Republic of China; Jiangsu Province Engineering Research Center of Precision Diagnostics and Therapeutics Development, Soochow University, Suzhou 215123, China.

Kunshan Hospital of Traditional Chinese Medicine, Kunshan, Jiangsu 215300, People's Republic of China; College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215123, People's Republic of China; Jiangsu Province Engineering Research Center of Precision Diagnostics and Therapeutics Development, Soochow University, Suzhou 215123, China; Department of Anatomy and Regenerative Medicine, Tissue Engineering Research Group, RCSI University of Medicine and Health Sciences, Dublin, Ireland.

出版信息

J Control Release. 2024 Sep;373:823-836. doi: 10.1016/j.jconrel.2024.07.077. Epub 2024 Aug 3.

Abstract

Precisely co-delivering antigens and immunosuppressants via nano/microcarriers to antigen-presenting cells (APCs) to induce antigen-specific immune tolerance represents a highly promising strategy for treating or preventing autoimmune diseases. The physicochemical properties of nano/microcarriers play a pivotal role in regulating immune function, with particle size and surface charge emerging as crucial parameters. In particular, very few studies have investigated micron-scale carriers of antigens. Herein, various nanoparticles and microparticles (NPs/MPs) with diverse particle sizes (ranging from 200 nm to 5 μm) and surface charges were prepared. Antigen peptides (MOG35-55) and immunosuppressants were encapsulated in these particles to induce antigen-specific immune tolerance. Two emulsifiers, PVA and PEMA, were employed to confer different surface charges to the NPs/MPs. The in vitro and in vivo studies demonstrated that NP/MP-PEMA could induce immune tolerance earlier than NP/MP-PVA and that NP/MP-PVA could induce immune tolerance more slowly and sustainably, indicating that highly negatively charged particles can induce immune tolerance more rapidly. Among the different sizes and charged particles tested, 200-nm-NP-PVA and 3-μm-MP-PEMA induced the greatest immune tolerance. In addition, the combination of NPs with MPs can further improve the induction of immune tolerance. In particular, combining 200 nm-NP-PVA with 3 μm-MP-PEMA or combining 500 nm-NP-PEMA with 3 μm-MP-PVA had optimal therapeutic efficacy. This study offers a new perspective for treating diseases by combining NPs with MPs and applying different emulsifiers to prepare NPs and MPs.

摘要

通过纳米/微载体将抗原和免疫抑制剂精确共递送至抗原呈递细胞(APC)以诱导抗原特异性免疫耐受,是治疗或预防自身免疫性疾病的一种极具前景的策略。纳米/微载体的物理化学性质在调节免疫功能中起着关键作用,粒径和表面电荷是关键参数。特别是,很少有研究调查微米级抗原载体。在此,制备了具有不同粒径(200纳米至5微米)和表面电荷的各种纳米颗粒和微米颗粒(NP/MP)。将抗原肽(MOG35-55)和免疫抑制剂包裹在这些颗粒中以诱导抗原特异性免疫耐受。使用两种乳化剂PVA和PEMA赋予NP/MP不同的表面电荷。体外和体内研究表明,NP/MP-PEMA比NP/MP-PVA能更早诱导免疫耐受,而NP/MP-PVA诱导免疫耐受的速度更慢且更持久,这表明高负电荷颗粒能更快诱导免疫耐受。在测试的不同尺寸和带电颗粒中,200纳米-NP-PVA和3微米-MP-PEMA诱导的免疫耐受最强。此外,NP与MP的组合可进一步提高免疫耐受的诱导效果。特别是,将200纳米-NP-PVA与3微米-MP-PEMA组合或将500纳米-NP-PEMA与3微米-MP-PVA组合具有最佳治疗效果。本研究为通过将NP与MP组合并应用不同乳化剂制备NP和MP来治疗疾病提供了新的视角。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验